Sikokianin E

CAS No. 2253791-96-5

Sikokianin E( ——— )

Catalog No. M38126 CAS No. 2253791-96-5

Sikokianin E is a biflavonone compound that can be isolated from Coreopsis tinctoria.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Sikokianin E
  • Note
    Research use only, not for human use.
  • Brief Description
    Sikokianin E is a biflavonone compound that can be isolated from Coreopsis tinctoria.
  • Description
    Sikokianin E is a biflavonone compound that can be isolated from Coreopsis tinctoria.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2253791-96-5
  • Formula Weight
    898.77
  • Molecular Formula
    C42H42O22
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Yan RJ, et al. Two new biflavonones from Coreopsis tinctoria. J Asian Nat Prod Res. 2017 Oct;19(10):960-965.?
molnova catalog
related products
  • Amyloid β-Protein (2...

    Amyloid β-Protein (25-35) amide

  • Ganoderic acid GS-2

    Ganoderic acid GS-2 can inhibit the activity of human immunodeficiency virus -1 protease.

  • [Pyr1]-Apelin-13

    [Pyr1]-Apelin-13 is a potent and selective endogenous Apelin receptor (APJ) agonist.[Pyr1]-apelin-13 encapsulation in lipoPEG particles (lipoPEG-PA13) results in sustained and extended drug release under physiological conditions[1].[Pyr1]-apelin-13 nanocarriers in a mouse model of pressure-overload induced heart failure demonstrate a sustainable long-term effect of [Pyr1]-apelin-13 in preventing cardiac dysfunction.